Rehmann Capital Advisory Group’s Integra LifeSciences IART Stock Holding History

Rehmann Capital Advisory Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$21.9K	Sell	364 -46	-11%	-$2.74K	﹤0.01%	847
2019 Q2	$22.9K	Buy	410 +59	+17%	+$3.04K	﹤0.01%	1102
2019 Q1	$19.6K	Sell	351 -22	-6%	-$1.12K	﹤0.01%	1132
2018 Q4	$16.8K	Hold	373	–	–	﹤0.01%	905
2018 Q3	$24.6K	Sell	373 -13	-3%	-$808	﹤0.01%	1054
2018 Q2	$24.9K	Buy	386 +60	+18%	+$3.71K	﹤0.01%	1027
2018 Q1	$18K	Buy	+326	New	+$17.1K	﹤0.01%	1104

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rehmann Capital Advisory Group's IART Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Integra LifeSciences (IART) stake by 11% in Q3 2019, selling an estimated $2.74K and leaving 364 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Rehmann Capital Advisory Group first reported a position in IART in Q1 2018 and has held it in 7 quarters since. The position peaked at $24.9K in Q2 2018. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Rehmann Capital Advisory Group held 364 shares of Integra LifeSciences worth $21.9K as of Q3 2019.
Rehmann Capital Advisory Group sold 46 Integra LifeSciences shares in Q3 2019, an estimated $2.74K.
Integra LifeSciences made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #847 holding.
Rehmann Capital Advisory Group first reported a position in Integra LifeSciences in Q1 2018 and has held it in 7 quarters since.
Rehmann Capital Advisory Group's Integra LifeSciences position peaked at $24.9K in Q2 2018.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.